Qualitative evaluation of caregiver preferences for peanut immunotherapy products

In the article "Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies,"1 the authors undertake the ambitious task of using qualitative research methods to describe the motivation and goals of caregivers of children with peanut allergy. This is a critically important area giv en the rapid increase in peanut allergy in the past 2 decades and the development of 2 different immunotherapy products, one or both of which will likely be approved by the US Food and Drug Administration and available for prescription by late 2019. (Source: Annals of Allergy, Asthma and Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Rp4z5V